期刊文献+

用套式基因扩增技术检测乙型肝炎病毒P基因区YMDD变异

Detection of YMDD mutation in HBV polymerase gene region with nested PCR
下载PDF
导出
摘要 目的 了解套式基因扩增 (nestedPCR)技术在检测HBVP基因区酪氨酸 -蛋氨酸 -天冬氨酸 -天冬氨酸 (YMDD)变异中的敏感性和特异性。方法 用套式基因扩增技术对 3组共 85例慢性乙型肝炎患者血清进行YMDD变异检测 ,检测结果经琼脂糖凝胶电泳判断。第 1组 :4 0例未经拉米夫定治疗 ,HBVDNA >5× 10 5拷贝 /ml;第 2组 :2 4例经拉米夫定治疗 6~ 18个月 ,HBVDNA≤ 5× 10 5拷贝 /ml;第 3组 :2 1例经拉米夫定治疗 6~ 18个月 ,HBVDNA >5× 10 5拷贝 /ml。结果 第 1组检出YVDD 2例、YVDD +YIDD 1例 ,检出率为 7.5 % ;第 2组检出YVDD、YIDD各 1例 ,检出率为 8.3% ;第 3组检出YVDD 4例、YIDD 2例、YVDD +YIDD 3例 ,检出率为 4 2 .9%。结论 套式基因扩增技术检测YMDD变异具有较高的敏感性和特异性 ,适合变异株快速检测 。 Objective To study the sensitivity and specificity of nested PCR for detection of YMDD mutation. Methods 85 serum samples from patients with chronic hepatitis B were divided in 3 groups: (1) 40 cases not treated with lamivudine, HBV DNA>5×10 5 copies/ml. (2) 24 cases treated with lamivudine for 6-18 months, HBV DNA ≤5×10 5 copies/ml. (3) 21 cases treated with lamivudine for 6-18 months, HBV DNA >5×10 5 copies/ml. Serum HBV DNA from these patients were amplified with nested PCR and then analyzed by electrophoresis. Results In the first group there were 2 YVDD mutation strains and 1 YVDD/YIDD mixed mutation strain, the rate of YMDD mutation was 7.5%. In the second group there was 1 YVDD and 1 YIDD mutation strains, the rate of YMDD mutation was 8.3% . In the third group there were 4 YVDD, 2 YIDD and 3 YVDD/YIDD mixed mutation strains, the rate of YMDD mutation was 42.9%. Conclusions The nested PCR is a high specific, sensitive and rapid method for detecting HBV YMDD mutation, especially for measurement of HBV YMDD mutation strains at the lower level.
出处 《上海医学检验杂志》 北大核心 2003年第5期261-264,共4页 Shanghai Journal of Medical Laboratory Sciences
关键词 慢性乙型肝炎 拉米夫定 套式基因扩增技术 YMDD Nested PCR Hepatitis B virus YMDD Mutation Lamivudine[HK
  • 相关文献

参考文献7

  • 1程新建,徐蓓,姚光弼.用PCR方法快速检测用拉米夫定治疗的乙型肝炎病人中HBV P基因区codon 550的变异[J].肝脏,2001,6(2):79-81. 被引量:7
  • 2姚光弼,王宝恩,崔振宇,姚集鲁,曾明德.拉米夫定治疗慢性乙型肝炎病人的长期疗效[J].中华肝脏病杂志,1999,7(2):80-83. 被引量:347
  • 3Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treament for chronic hepatitis B in the United States[J]. N Engl J Med, 1999,341:1256-1263.
  • 4Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutation in hepatitis B virus resistant to lamivudine clinical investigation [ J ].Hepatology, 1998,27 : 1670-1677.
  • 5Cane PA, Cook P, Ratcliffe D, et al. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus [ J ]. Antimicrob Agents Chemozher, 1999,43:1600-1608.
  • 6Kobayashi S, Ide T, Sata M, et al. Detection of YMDD matif mutations in some lamivudine untreated asymptomatic hepatitis B virus carriers[J]. J Hepatol,2001,34:584-586.
  • 7Whalley SA, Brown D, Teo CG, et al. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine-therapy using the light cycler[J]. J Clin Microliol, 2001,39:1456-1459.

二级参考文献5

  • 1Yao G B,Chin Med J,1999年,112卷,387页
  • 2Lai C L,N Eng J Med,1998年,339卷,61页
  • 3Lai C L,Hepatology,1997年,25卷,241页
  • 4Doong S L,Proc Natl Acad Sci,1991年,88卷,8495页
  • 5Cane PA,Cook P,Ratcliffe D,et al.Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus[].Antimicrobial Agents and Chemotherapy.1999

共引文献350

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部